These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
475 related items for PubMed ID: 27853934
1. Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone. Giri P, Naidu S, Patel N, Patel H, Srinivas NR. Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):677-688. PubMed ID: 27853934 [Abstract] [Full Text] [Related]
2. In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies. Wang L, Zhang D, Raghavan N, Yao M, Ma L, Frost CE, Maxwell BD, Chen SY, He K, Goosen TC, Humphreys WG, Grossman SJ. Drug Metab Dispos; 2010 Mar; 38(3):448-58. PubMed ID: 19940026 [Abstract] [Full Text] [Related]
8. Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes. Linnet K, Olesen OV. Drug Metab Dispos; 1997 Dec; 25(12):1379-82. PubMed ID: 9394027 [Abstract] [Full Text] [Related]
9. In vitro cytochrome P450- and transporter-mediated drug interaction potential of 6β-hydroxy-21-desacetyl deflazacort-A major human metabolite of deflazacort. Ma J, Beers B, Manohar R, Roe S, Colacino JM, Kong R. Pharmacol Res Perspect; 2021 Apr; 9(2):e00748. PubMed ID: 33749127 [Abstract] [Full Text] [Related]
10. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies. Hua X, Peng X, Tan S, Li C, Wang W, Luo M, Fu Y, Zu Y, Smyth H. J Agric Food Chem; 2014 Oct 29; 62(43):10604-14. PubMed ID: 25272989 [Abstract] [Full Text] [Related]
14. In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes. Zhang N, Liu J, Chen Z, Dou W. Pharm Biol; 2019 Dec 29; 57(1):571-576. PubMed ID: 31456483 [Abstract] [Full Text] [Related]
17. In vitro inhibition of human liver cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes by rose bengal: system-dependent effects on inhibitory potential. Kazmi F, Haupt LJ, Horkman JR, Smith BD, Buckley DB, Wachter EA, Singer JM. Xenobiotica; 2014 Jul 29; 44(7):606-14. PubMed ID: 24405273 [Abstract] [Full Text] [Related]
18. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans. Mössner LD, Schmitz A, Theurillat R, Thormann W, Mevissen M. Am J Vet Res; 2011 Nov 29; 72(11):1505-13. PubMed ID: 22023129 [Abstract] [Full Text] [Related]
19. In Vitro Assessment of Potential for CYP-Inhibition-Based Drug-Drug Interaction Between Vonoprazan and Clopidogrel. Nishihara M, Yamasaki H, Czerniak R, Jenkins H. Eur J Drug Metab Pharmacokinet; 2019 Apr 29; 44(2):217-227. PubMed ID: 30361928 [Abstract] [Full Text] [Related]
20. Evaluation of in vitro inhibition and induction of cytochrome P450 activities by hydrolyzed ginkgolides. Zhou XW, Ma Z, Geng T, Wang ZZ, Ding G, Yu-an B, Xiao W. J Ethnopharmacol; 2014 Dec 02; 158 Pt A():132-9. PubMed ID: 25456428 [Abstract] [Full Text] [Related] Page: [Next] [New Search]